16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
López-Torres MO, Marquina-Castillo B, Ramos-Espinosa O, Mata-Espinosa D, Barrios-Payan JA, Baay-Guzman G, Yepez SH, Bini E, Torre-Villalvazo I, Torres N, Tovar A, Chamberlin W, Ge Y, Carranza A, Hernández-Pando R.
López-Torres MO, et al.
Clin Exp Immunol. 2021 Aug;205(2):232-245. doi: 10.1111/cei.13603. Epub 2021 Jun 1.
Clin Exp Immunol. 2021.
PMID: 33866550
Free PMC article.